相关实验视频
Updated: May 5, 2026

13:01
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
134.2K
在接受疾病修饰治疗的类风湿性关节炎患者中,抗素蛋白抗体的演变:前性队列研究
Chaimae Charoui1, Bouchra Amine1, Imane El Binoune1
1Rheumatology A, El Ayachi Hospital, Ibn Sina University Hospital, University Mohamed V, Rabat, MAR.
Cureus
|April 7, 2025
概括
在接受Rituximab (RTX) 治疗的类风湿性关节炎 (RA) 患者中,抗素蛋白抗体 (ACPA) 水平显著降低. 这表明RTX可能有助于在RA患者中实现免疫性缓解.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 类风湿性关节炎 (RA) 是一种自身免疫性疾病,其特点是炎症和关节损伤.
- 抗素蛋白抗体 (ACPA) 是RA诊断和预后的关键生物标志物.
- 疾病修饰性抗风湿药物 (DMARDs) 是对RA的标准治疗方法,而像Rituximab (RTX) 这样的生物药物用于耐火病例.
研究的目的:
- 描述RA患者接受疾病修饰疗法的ACPA水平的变化.
- 为了评估ACPA水平如何随疾病活动而变化.
- 为了识别具有负ACPA的RA患者的特征.
主要方法:
- 在90名ACPA阳性RA患者的前性研究中,疾病活动指数 (DAS) >2.6.
- 患者接受了利图西马布 (RTX) 或其他DMARDs (TNFi,抗IL6,csDMARDs).
- 在基线 (M0),6个月 (M6) 和12个月 (M12) 通过ELISA测量ACPA水平.
主要成果:
- 整体ACPA水平在12个月内显著下降 (p<0.001).
- 与没有RTX组 (p=0.26) 相比,RTX组显示了ACPA水平的显著降低 (p<0.001).
- 在12个月后,30%的患者实现了缓解 (DAS28得分),他们的ACPA水平显著下降.
结论:
- 在接受RTX治疗的RA患者中,ACPA抗体水平在现实环境中显著下降.
- 利图西马布治疗可能有助于在RA中实现免疫性缓解.
- 需要进一步的研究来探索RTX在调节ACPA水平和疾病活性中的作用.
相关概念视频
Genome-wide Association Studies-GWAS
12.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
780
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
780
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
897
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
897
Rheumatic Heart Disease I: Introduction
1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease III: Medical Management
548
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
548

